Published 2014
| Version v1
Journal article
EUROFANCOLEN Project
Creators
Description
The first follow-up report of European Project EUROFANCOLEN, the purpose of which is to develop a gene therapy clinical trial to resolve bone marrow failure in patients with a genetic disease known as Fanconi anemia (FA), was sent to the European Commission in September. The main objective of project EUROFANCOLEN is to develop a gene therapy trial for patients with Fanconi anemia Type A (FA-A), which affects 80% of the patients with FA in Spain. (Author)
Availability note (English)
Available http://www.ciemat.es/portal.do?IDM=226&NM=3Additional details
Additional titles
- Original title (Spanish)
- El Proyecto EUROFANCOLEN
Identifiers
Publishing Information
- Journal Title
- Vertices
- Journal Volume
- 22
- Journal Page Range
- p. 30-31
- ISSN
- 1887-1461
INIS
- Country of Publication
- Spain
- Country of Input or Organization
- Spain
- INIS RN
- 46013171
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BONE MARROW; BONE TISSUES; GENE THERAPY; HEMATOPOIETIC SYSTEM; MEDICINE; STEM CELLS; THERAPY
- Descriptors DEC
- ANIMAL CELLS; ANIMAL TISSUES; BODY; CONNECTIVE TISSUE; HEMATOPOIETIC SYSTEM; MEDICINE; ORGANS; SOMATIC CELLS; THERAPY